A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Clinical trial NCT06249438 · RECRUITING

Trial details

NCT number: NCT06249438
Sponsor: RenJi Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Immune-mediated Necrotizing Myopathy (IMNM)Neuromyelitis Optica Spectrum Disorders (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis Systemic Sclerosis (SSc)

Start date: 2024-03-20
Primary completion: 2027-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.